Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Lung Neoplasms 4Head and Neck Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Uterine Cervical Neoplasms 2Adenocarcinoma of Lung 2Unspecified Childhood Solid Tumor, Protocol Specific 1Unspecified Adult Solid Tumor, Protocol Specific 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Ovarian Neoplasms 1Limited Stage Small Cell Lung Cancer 1Laryngeal Diseases 1Carcinoma, Squamous Cell 1Carcinoma, Ovarian Epithelial 1Alveolar Childhood Rhabdomyosarcoma 1

Interventions

Irinotecan 6Cyclophosphamide 3temsirolimus 2Sirolimus 2Early Intervention, Educational 2reolysin 1irofulven 1cixutumumab 1aflibercept 1Vincristine 1Trabectedin 1Tirapazamine 1Thalidomide 1Temozolomide 1Pemetrexed 1Oxaliplatin 1Immunohistochemistry 1Gemcitabine 1Gefitinib 1Filgrastim 1Enzyme-Linked Immunosorbent Assay 1Counseling 1Cisplatin 1Carboplatin 1Bortezomib 1Bevacizumab 1Amifostine 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Unspecified Childhood Solid Tumor, Protocol Specific × Tirapazamine × Clear all
NCT00003288 2013-02-05

Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
12 enrolled
Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡